Aethlon Medical Inc (NASDAQ:AEMD)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 1.81. At the close of trading, the stock’s price was $0.52, to imply a decrease of -7.50% or -$0.04 in intraday trading. The AEMD share’s 52-week high remains $1.85, putting it -255.77% down since that peak but still an impressive 53.85% since price per share fell to its 52-week low of $0.24.

Analysts have given a consensus recommendation of Buy for Aethlon Medical Inc (AEMD), translating to a mean rating of 2.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give AEMD a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.14.

Aethlon Medical Inc (NASDAQ:AEMD) trade information

After registering a -7.50% downside in the last session, Aethlon Medical Inc (AEMD) has traded red over the past five days. The 5-day price performance for the stock is -11.26%, and -30.14% over 30 days. With these gigs, the year-to-date price performance is -39.80%.

AEMD Dividends

Aethlon Medical Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Aethlon Medical Inc (AEMD) shares. Going by data provided on Dec 31, 2024 , Fidelity Extended Market Index Fund holds roughly 72.79 shares. This is just over 0.50% of the total shares, with a market valuation of $37682.0. Data from the same date shows that the other fund manager holds a little less at 21.22, or 0.15% of the shares, all valued at about 10987.0.